HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

University of Minnesota (UMN)

Status: Enrolling

Conditions: Hypertension; Hypertensive Disorder of Pregnancy; Postpartum

Treatments: Diagnostic Test: 6-Week Home Monitoring; Diagnostic Test: 2-Week Home Monitoring

Study type: Interventional

Funder types: Other

Identifiers

NCT07204756

OBGYN-2025-34107

Details and patient eligibility

About

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

Enrollment: 400 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years or older
• Discharged after delivery at University of Minnesota Medical Center
• Enrolled into the HOPE-BP Program

Exclusion criteria

• Ongoing antihypertensive medication use at 2 weeks (time of randomization)
• Have a medical comorbidity that would not be clinically appropriate to randomize
• Patients opted out of clinical research

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

400 participants in 2 patient groups

2-Week Arm

Active Comparator group

Description:

Participants randomized into the 2 week arm will be immediately unenrolled from the postpartum remote blood pressure monitoring program and resume standard postpartum care

Treatment:

Diagnostic Test: 2-Week Home Monitoring

6-Week Arm

Active Comparator group

Description:

Patients randomized into the 6 week arm will continue and complete the program in its entirety per current SOC (4 additional weeks)

Treatment:

Diagnostic Test: 6-Week Home Monitoring